News & Events

The StageBio team is looking forward to attending the 62nd Annual SOT Annual Meeting & Expo held March 19-23 in Nashville, Tennessee.

StageBio Distinguished Pathologist Dr. Serge Rousselle, DVM, DACVP, recently gave a webinar presentation  on the key considerations of accurate evaluation for medical device safety, efficacy, healing, and biocompatibility in nonclinical assessments.

StageBio is now offering Biorepository Services in addition to Archiving Services for clients. This service is now available globally and StageBio can facilitate the transportation of materials internationally.

StageBio, a leading international provider of GLP-compliant research, preclinical and clinical histopathology and biospecimen archiving services for the life sciences industry, announces that Ms. Kimberly Uptgraft has been appointed to Senior Vice President, Operations of StageBio.

StageBio, a leading international provider of GLP-compliant research, preclinical and clinical histopathology and biospecimen archiving services for life sciences industry, announces that Ms. Lecia Johnson has been appointed to Vice President, Commercial of StageBio.

Upgraded technology now enables StageBio to service clients in Europe.

It is with great honor that we congratulate Melanie Willis, CVT, BS, RQAP-GLP, Senior Quality Assurance Auditor, she has been elected as the inaugural SQA Director for Diversity, Inclusion, and Belonging.

StageBio is honored to introduce Lori A. Wright, RQAP-GLP, Senior Director, Quality and Regulatory.

StageBio is honored to introduce Dr. Juliana Lee, BVSc, MS, DACVP as Interim Director, Medical Device Pathology.

The StageBio team is looking forward to attending ESMO Congress 2022 in Paris, France, September 9-13, and we hope to see you there!